Page last updated: 2024-08-26
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Basophilic Leukemia, Acute
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Basophilic Leukemia, Acute in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kang, LT; Vanderhoek, JY | 1 |
Other Studies
1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Basophilic Leukemia, Acute
Article | Year |
---|---|
Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Binding Sites; Binding, Competitive; Calcimycin; Cell Line; Cholic Acids; Dinoprost; Hydroxyeicosatetraenoic Acids; Leukemia, Basophilic, Acute; Lipoxygenase Inhibitors; Rats; Subcellular Fractions; Tumor Cells, Cultured | 1995 |